These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29131397)

  • 1. A Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease.
    Takenaka M; Iio A; Sato R; Sakamoto T; Kurumatani H;
    J Vet Intern Med; 2018 Jan; 32(1):236-248. PubMed ID: 29131397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial.
    Koyama A; Fujita T; Gejyo F; Origasa H; Isono M; Kurumatani H; Okada K; Kanoh H; Kiriyama T; Yamada S
    BMC Nephrol; 2015 Oct; 16():165. PubMed ID: 26475266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study.
    Kurumatani H; Okada K; Origasa H; Fujita T; Isono M; Nakamoto H
    Ther Apher Dial; 2021 Oct; 25(5):551-564. PubMed ID: 33340238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.
    Sent U; Gössl R; Elliott J; Syme HM; Zimmering T
    J Vet Intern Med; 2015; 29(6):1479-87. PubMed ID: 26474314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appetite-stimulating effects of once-daily omeprazole in cats with chronic kidney disease: Double-blind, placebo-controlled, randomized, crossover trial.
    Spencer A; Quimby JM; Price JM; MacLane S; Hillsman S; Secoura P; Steiner JM; Katherine Tolbert M
    J Vet Intern Med; 2021 Nov; 35(6):2705-2712. PubMed ID: 34590746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and efficacy of benazepril in cats with chronic kidney disease.
    King JN; Gunn-Moore DA; Tasker S; Gleadhill A; Strehlau G;
    J Vet Intern Med; 2006; 20(5):1054-64. PubMed ID: 17063696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial.
    Quimby JM; Brock WT; Moses K; Bolotin D; Patricelli K
    J Feline Med Surg; 2015 Aug; 17(8):692-7. PubMed ID: 25336450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in cats with chronic kidney disease.
    King JN; Tasker S; Gunn-Moore DA; Strehlau G;
    J Vet Intern Med; 2007; 21(5):906-16. PubMed ID: 17939542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats.
    Quimby JM; Webb TL; Randall E; Marolf A; Valdes-Martinez A; Dow SW
    J Feline Med Surg; 2016 Feb; 18(2):165-71. PubMed ID: 25784460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group.
    Lièvre M; Morand S; Besse B; Fiessinger JN; Boissel JP
    Circulation; 2000 Jul; 102(4):426-31. PubMed ID: 10908215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-dose meloxicam in cats with chronic kidney disease.
    KuKanich K; George C; Roush JK; Sharp S; Farace G; Yerramilli M; Peterson S; Grauer GF
    J Feline Med Surg; 2021 Feb; 23(2):138-148. PubMed ID: 32594827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria.
    Choi YM; Kwon HS; Choi KM; Lee WY; Hong EG
    Endocrinol Metab (Seoul); 2019 Dec; 34(4):398-405. PubMed ID: 31884740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective case-control study of the effects of long-term dosing with meloxicam on renal function in aged cats with degenerative joint disease.
    Gowan RA; Lingard AE; Johnston L; Stansen W; Brown SA; Malik R
    J Feline Med Surg; 2011 Oct; 13(10):752-61. PubMed ID: 21906984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy.
    Na KY; Kim DK; Kim SG; Lee YK; Lim CS
    Trials; 2013 Sep; 14():275. PubMed ID: 24066672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Chinese rhubarb, Rheum officinale, with and without benazepril on the progression of naturally occurring chronic kidney disease in cats.
    Hanzlicek AS; Roof CJ; Sanderson MW; Grauer GF
    J Vet Intern Med; 2014; 28(4):1221-8. PubMed ID: 24773179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.
    Quimby JM; Benson KK; Summers SC; Saffire A; Herndon AK; Bai S; Gustafson DL
    J Feline Med Surg; 2020 Apr; 22(4):376-383. PubMed ID: 31161850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effect of an oral prostacyclin analog, beraprost sodium, on digital necrosis in systemic sclerosis. French Microcirculation Society Multicenter Group for the Study of Vascular Acrosyndromes.
    Vayssairat M
    J Rheumatol; 1999 Oct; 26(10):2173-8. PubMed ID: 10529135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Sustained-Release Beraprost in Patients With Primary Glomerular Disease or Nephrosclerosis: CASSIOPEIR Study Results.
    Nakamoto H; Yu XQ; Kim S; Origasa H; Zheng H; Chen J; Joo KW; Sritippayawan S; Chen Q; Chen HC; Tsubakihara Y; Tamai H; Song SH; Vaithilingam I; Lee KW; Shu KH; Hok-King Lo S; Isono M; Kurumatani H; Okada K; Kanoh H; Kiriyama T; Yamada S; Fujita T
    Ther Apher Dial; 2020 Feb; 24(1):42-55. PubMed ID: 31119846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
    Quimby JM; Lunn KF
    Vet J; 2013 Sep; 197(3):651-5. PubMed ID: 23838205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beraprost Sodium Protects Against Diabetic Nephropathy in Patients with Arteriosclerosis Obliterans: A Prospective, Randomized, Open-label Study.
    Shima A; Miyamoto M; Kubota Y; Takagi G; Shimizu W
    J Nippon Med Sch; 2015; 82(2):84-91. PubMed ID: 25959199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.